Clinic
Island Kids Pediatrics, P.C.
Island Kids Pediatrics, P.C. was paid $9.15M by Medicaid between Jan 2018 and Oct 2023, across 94 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoISLAND KIDS PEDIATRICS, P.C.
STATEN ISLAND, NY 10314
STATEN ISLAND, NY 10314
33aNPI1487792024assigned 02/04/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$9.15M
24GClaims245,407
24DCodes billed94
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Primary Care Clinic/Center providers in New York
Rank by total paid#9 of 242
Median peer was paid$172K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,150 | $989K | |
| 2019 | 39,594 | $1.42M | |
| 2020 | 39,308 | $1.36M | |
| 2021 | 44,605 | $1.74M | |
| 2022 | 53,338 | $2.00M | |
| 2023 | 42,412 | $1.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 40,887 | 35,086 | $3.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 20,435 | 18,076 | $2.21M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.1% | 5,888 | 5,882 | $560K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.6% | 21,124 | 20,733 | $514K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.6% | 5,271 | 5,271 | $511K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 4,419 | 4,220 | $380K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.9% | 3,302 | 3,302 | $353K |
| 92567 | 2.9% | 19,391 | 19,077 | $267K | |
| 92587 | 1.7% | 7,905 | 7,812 | $151K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 4,973 | 4,813 | $104K |
| 92551 | 1.1% | 10,440 | 10,401 | $103K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 5,934 | 5,707 | $99K |
82 more codes
| 99051 | 1.0% | 16,779 | $95K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,816 | $83K |
| 90461 | <1% | 3,022 | $77K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 10,879 | $74K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 531 | $58K |
| 99188 | <1% | 3,369 | $48K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,698 | $47K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 493 | $45K |
| 99402 | <1% | 859 | $40K | |
| 99177 | <1% | 10,916 | $31K | |
| 99401 | <1% | 767 | $25K | |
| 96127 | <1% | 4,628 | $22K | |
| 96160 | <1% | 4,303 | $18K | |
| 99383 | <1% | 115 | $12K | |
| 94010 | <1% | 365 | $11K | |
| 0071A | <1% | 334 | $10K | |
| 0072A | <1% | 302 | $10K | |
| 97802 | <1% | 492 | $10K | |
| 99404 | <1% | 109 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 46 | $7K |
| 98960 | <1% | 455 | $7K | |
| 99441 | <1% | 223 | $7K | |
| 99382 | <1% | 58 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,217 | $5K |
| 99381 | <1% | 48 | $4K | |
| 96161 | <1% | 2,619 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 272 | $4K |
| 99403 | <1% | 59 | $4K | |
| 90686 | <1% | 3,171 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 252 | $3K |
| 90651 | <1% | 227 | $3K | |
| 90670 | <1% | 1,728 | $3K | |
| 93000 | <1% | 153 | $2K | |
| 0002A | <1% | 66 | $2K | |
| 97803 | <1% | 70 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 157 | $2K |
| 94664 | <1% | 134 | $2K | |
| 81003 | <1% | 1,316 | $2K | |
| 0001A | <1% | 44 | $1K | |
| 99422 | <1% | 39 | $1K | |
| 99421 | <1% | 65 | $929.22 | |
| 90619 | <1% | 424 | $900.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 55 | $683.32 |
| 90715 | <1% | 141 | $617.53 | |
| 99173 | <1% | 432 | $565.41 | |
| 90716 | <1% | 271 | $492.06 | |
| 90744 | <1% | 807 | $462.18 | |
| 99072 | <1% | 519 | $443.00 | |
| 90707 | <1% | 251 | $328.52 | |
| 90710 | <1% | 103 | $298.53 | |
| 90672 | <1% | 34 | $268.80 | |
| 94760 | <1% | 196 | $256.23 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 376 | $242.16 |
| 90633 | <1% | 793 | $232.90 | |
| 87999 | <1% | 453 | $192.50 | |
| 91307 | <1% | 673 | $169.89 | |
| 90734 | <1% | 214 | $146.62 | |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 163 | $136.14 |
| 36415 | Collection of venous blood by venipuncture | <1% | 182 | $112.05 |
| 36416 | <1% | 3,051 | $72.71 | |
| 78267 | <1% | 13 | $56.20 | |
| 91300 | <1% | 202 | $50.91 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 33 | $23.27 |
| 81002 | <1% | 12 | $20.13 | |
| 90680 | <1% | 831 | $17.85 | |
| 90698 | <1% | 1,113 | $17.85 | |
| H0033 | Oral medication administration, direct observation | <1% | 1,257 | $17.28 |
| G9432 | Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented | <1% | 1,013 | $10.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 71 | $2.61 |
| 5250F | 0% | 705 | $0.00 | |
| 90648 | 0% | 70 | $0.00 | |
| G9434 | Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given | 0% | 24 | $0.00 |
| 90685 | 0% | 131 | $0.00 | |
| 90700 | 0% | 210 | $0.00 | |
| 90713 | 0% | 16 | $0.00 | |
| 99080 | 0% | 51 | $0.00 | |
| 90696 | 0% | 165 | $0.00 | |
| S8301 | Infection control supplies, not otherwise specified | 0% | 22 | $0.00 |
| 3008F | 0% | 16 | $0.00 | |
| 99058 | 0% | 50 | $0.00 | |
| 99000 | 0% | 53 | $0.00 | |
| 99070 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCEREB, DENIZ (PRESIDENT)